Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection.

Hannan TJ, Mysorekar IU, Hung CS, Isaacson-Schmid ML, Hultgren SJ.

PLoS Pathog. 2010 Aug 12;6(8):e1001042. doi: 10.1371/journal.ppat.1001042.

2.

Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Hannan TJ, Totsika M, Mansfield KJ, Moore KH, Schembri MA, Hultgren SJ.

FEMS Microbiol Rev. 2012 May;36(3):616-48. doi: 10.1111/j.1574-6976.2012.00339.x. Review.

3.

Are you experienced? Understanding bladder innate immunity in the context of recurrent urinary tract infection.

O'Brien VP, Hannan TJ, Schaeffer AJ, Hultgren SJ.

Curr Opin Infect Dis. 2015 Feb;28(1):97-105. doi: 10.1097/QCO.0000000000000130. Review.

4.

Theodore E. Woodward Award: host-pathogen interactions in community-acquired urinary tract infections.

Stamm WE.

Trans Am Clin Climatol Assoc. 2006;117:75-83; discussion 83-4. Review.

5.

Mechanisms of pain from urinary tract infection.

Rosen JM, Klumpp DJ.

Int J Urol. 2014 Apr;21 Suppl 1:26-32. doi: 10.1111/iju.12309. Review.

6.

Dynamic interactions between host and pathogen during acute urinary tract infections.

Schilling JD, Mulvey MA, Hultgren SJ.

Urology. 2001 Jun;57(6 Suppl 1):56-61. Review.

PMID:
11378051
7.

Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses.

Mulvey MA, Schilling JD, Martinez JJ, Hultgren SJ.

Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):8829-35. Review.

8.

Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection.

Ulett GC, Totsika M, Schaale K, Carey AJ, Sweet MJ, Schembri MA.

Curr Opin Microbiol. 2013 Feb;16(1):100-7. doi: 10.1016/j.mib.2013.01.005. Epub 2013 Feb 8. Review.

PMID:
23403118
9.

Uropathogenic Escherichia coli as a model of host-parasite interaction.

Svanborg C, Bergsten G, Fischer H, Godaly G, Gustafsson M, Karpman D, Lundstedt AC, Ragnarsdottir B, Svensson M, Wullt B.

Curr Opin Microbiol. 2006 Feb;9(1):33-9. Epub 2006 Jan 6. Review.

PMID:
16406777
10.
11.

Innate immunity and genetic determinants of urinary tract infection susceptibility.

Godaly G, Ambite I, Svanborg C.

Curr Opin Infect Dis. 2015 Feb;28(1):88-96. doi: 10.1097/QCO.0000000000000127. Review.

12.

Virulence factors of uropathogenic E. coli and their interaction with the host.

Lüthje P, Brauner A.

Adv Microb Physiol. 2014;65:337-72. doi: 10.1016/bs.ampbs.2014.08.006. Epub 2014 Nov 4. Review.

PMID:
25476769
13.

Interaction of uropathogenic Escherichia coli with host uroepithelium.

Kau AL, Hunstad DA, Hultgren SJ.

Curr Opin Microbiol. 2005 Feb;8(1):54-9. Review.

PMID:
15694857
14.

Subversion of Host Innate Immunity by Uropathogenic Escherichia coli.

Olson PD, Hunstad DA.

Pathogens. 2016 Jan 4;5(1). pii: E2. doi: 10.3390/pathogens5010002. Review.

15.

Innate defences and resistance to gram negative mucosal infection.

Godaly G, Bergsten G, Frendéus B, Hang L, Hedlund M, Karpman D, Samuelsson P, Svensson M, Otto G, Wullt B, Svanborg C.

Adv Exp Med Biol. 2000;485:9-24. Review. No abstract available.

PMID:
11109082
16.

Susceptibility to Urinary Tract Infection: Benefits and Hazards of the Antibacterial Host Response.

Ambite I, Nagy K, Godaly G, Puthia M, Wullt B, Svanborg C.

Microbiol Spectr. 2016 Jun;4(3). doi: 10.1128/microbiolspec.UTI-0019-2014. Review.

PMID:
27337480
17.

Why Serological Responses during Cystitis are Limited.

Choi HW, Abraham SN.

Pathogens. 2016 Feb 14;5(1). pii: E19. doi: 10.3390/pathogens5010019. Review.

Supplemental Content

Support Center